Plasma Immunoglobulin A Responses Against 2SalmonellaTyphi Antigens Identify Patients With Typhoid Fever
Year: 2018
Type: article
Study design: Observational Study
Abstract: BACKGROUND: There is a need for a reliable, simple diagnostic assay for typhoid fever. Available commercial serologic assays for typhoid fever have limited sensitivity and specificity. Using high-throughput immunoscreening technologies, we previously identified several immunoreactive Salmonella Typhi antigens that seem promising for possible inclusion in a new diagnostic assay: hemolysin E (HlyE), cytolethal distending toxin, S. Typhi lipopolysaccharide (LPS), and S. Typhi membrane preparation. METHODS: We assessed plasma antibody responses (immunoglobulin [Ig] M, IgA, and IgG) to these antigens by means of enzyme-linked immunosorbent assay in patients with suspected enteric fever, controls with other febrile illnesses, and healthy controls in Dhaka, Bangladesh and performed Tubex and Typhidot tests, the Widal assay, and the typhoid/paratyphoid test (TPTest) in each patient. Using machine learning methods, we identified a parsimonious serology signature to distinguish acute typhoid cases from controls and then validated our findings in an independent test cohort from Nepal of patients with culture-confirmed S. Typhi and controls with other bacteremic illnesses. RESULTS: We demonstrated that the use of 2 antigens (HlyE and LPS) with 1 antibody isotype (IgA) could distinguish typhoid from other invasive bacterial infections (area under the receiver operating characteristic curve [AUC], 0.95; sensitivity, 90%, specificity, 92%). Use of a single antigen (HlyE) and isotype (IgA) had an AUC of 0.93. CONCLUSION: Our results suggest that development of a diagnostic assay for acute typhoid fever focused on detecting IgA responses against HlyE, with or without LPS, is warranted.
Source: Clinical Infectious Diseases
DOI: 10.1093/cid/ciy578
Language: English
Subfield: Food Science
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $4,763
Funders: Bill and Melinda Gates Foundation, Robert Wood Johnson Foundation, Massachusetts General Hospital, Global Affairs Canada, International Centre for Diarrhoeal Disease Research, Bangladesh, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Fogarty International Center, National Institute of Diabetes and Digestive and Kidney Diseases
Awards: Improving diagnostic capabilities for typhoid fever, G1510978416, Detection of asymptomatic Salmonella enterica serotype Typhi and Paratyphi A carriage by serum antibodies targeting YncE, G6525324410, Humoral and adaptive immune responses study in Vibrio cholerae infection, Center for the Study of Inflammatory Bowel Disease at Massachusetts General Hospital, International research training program in vaccine development and public health
OpenAlex ID: W2883189976
